# Silent Micro-Hemorrhage Of Brain Target-Met Run

Date/time: 2026-05-08T07:02:41Z

## Selected Focus

Silent micro-hemorrhage of brain.

## Why This Was Chosen

The MR-RATE disease research queue is processed sequentially from
`manifest.json`. Cerebral infarction, lacunar infarct, watershed infarct, and
cerebral hemorrhage had already reached the thorough-research evidence-count
target. Silent micro-hemorrhage of brain was the next disease below target.

## Work Performed

- Expanded `sources.json` from 18 to 50 source records.
- Expanded `figures.json` from 10 to 25 figure evidence records.
- Expanded `videos.json` from 6 to 15 video evidence records.
- Updated slug-prefixed evidence aliases:
  `silent-micro-hemorrhage-of-brain.sources.json`,
  `silent-micro-hemorrhage-of-brain.figures.json`, and
  `silent-micro-hemorrhage-of-brain.videos.json`.
- Updated `silent-micro-hemorrhage-of-brain.md` to mark the evidence-count
  target as met while preserving expert review, transcript review, and figure
  reuse review as remaining publication gates.
- Updated `source-review.md` and `research-plan.md` with a final evidence-count
  maturity checkpoint.
- Updated slug-prefixed review aliases:
  `silent-micro-hemorrhage-of-brain.research-plan.md` and
  `silent-micro-hemorrhage-of-brain.source-review.md`.
- Updated `manifest.json` and `TODO.md` so restart logic can continue with the
  next below-target disease.
- Regenerated the silent micro-hemorrhage HTML preview.
- Refreshed the MR-RATE disease research index.

## Evidence Progress

- Sources: 50/50.
- Figures: 25/25.
- Videos: 15/15.

## Source Areas Added

- Spontaneous microbleed study standards and the Microbleed Study Group
  detection/interpretation guide.
- MARS and BOMBS rating frameworks.
- QSM, automated detection, and automated size/location characterization.
- Rotterdam population imaging and lobar topography evidence.
- CAA, hypertensive arteriopathy, cortical superficial siderosis, and
  histopathology correlation sources.
- Antiplatelet, thrombolysis, recurrent stroke/ICH, mortality, dementia, and
  functional outcome sources.
- ARIA-H monitoring and anti-amyloid therapy MRI guidance.
- Traumatic microbleed/DAI and cavernous malformation mimic context.

## Commands And Checks

- Ran deterministic evidence expansion helper; it reported `ok: true` with 32
  sources, 15 figures, and 9 videos added.
- Ran JSON parse checks for `sources.json`, `figures.json`, `videos.json`,
  slug-prefixed aliases, and `manifest.json`; all passed.
- Ran `python -m skillforge disease-template-check
  silent-micro-hemorrhage-of-brain --json`; it reported `ok: true`, exact
  strict headings present, 50 source records, 25 figure records, and supporting
  artifact aliases present.
- Ran `python -m skillforge disease-preview
  silent-micro-hemorrhage-of-brain --json`; it reported `ok: true` and
  regenerated `reports/diseases/silent-micro-hemorrhage-of-brain.html`.
- Refreshed `reports/index.html`; the queue status now shows five diseases at
  `final_thorough_research_target_met_needs_human_review`.

## What Worked

- The chapter already passed template conformance, so the cycle focused on
  evidence depth and artifact maturity.
- The evidence set now covers the main clinical-statistical risks: protocol
  dependence, reader reliability, burden thresholds, etiologic distribution,
  treatment exposure, longitudinal comparability, and mimic separation.
- URL-only figure and video records allowed safe progress without downloading
  assets, using credentials, or processing private clinical data.

## What Could Be Improved

- Figure reuse rights still need review before any local image embedding.
- Video transcripts were not reviewed; videos remain candidate teaching
  evidence.
- A future refinement pass should add a compact burden/categorization table
  using MARS, BOMBS, and ARIA-H severity categories.

## Blockers Or Gaps

- No blocker stopped the cycle.
- PMC and PubMed pages intermittently presented client-challenge pages, so many
  records remain URL-only.
- Human expert review is still required before publication.
- Treatment-risk and ARIA-H language should remain research/pathway framing
  until reviewed.

## Next Action

Continue the queue with `cavernous-hemangioma`, currently below target and in
the `authoritative_source_discovery_started` state.
